You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博雅生物(300294.SZ):資產重組事項將於2月18日上會
格隆匯 02-12 18:52

格隆匯2月12日丨博雅生物(300294.SZ)公佈,中國證監會於2020年2月12日在其官方網站上發佈了《併購重組委2020年第4次工作會議公告》,中國證監會上市公司併購重組審核委員會(“併購重組委”)定於2020年2月18日上午9:00召開2020年第4次併購重組委工作會議,對公司發行股份、可轉換公司債券及支付現金購買資產暨關聯交易事項進行審核,公司已向中國證監會上市公司監管部出具了《關於保證不影響和干擾併購重組審核委員會審核的承諾函》。

為維護廣大投資者利益,避免引起公司股價異常波動,根據相關規定,公司股將在2020年2月18日併購重組委工作會議召開當天停牌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account